Flow cytometric analysis of Human CD289 expression on Human PBMC. Human PBMC (peripheral blood mononuclear cells) were stained with PE-Cy7 Mouse Anti-Human CD123 Antibody and either Alexa Fluor® 488 Rat IgG2a, κ Isotype Control (Left panel) or SDT Alexa Fluor® 488 Rat Anti-Human CD289 Antibody (Right panel) at 1.25 μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.
Product Details
Product Details
Product Specification
Host | Rat |
Antigen | CD289 |
Synonyms | Toll-like receptor 9; TLR9 |
Location | Endoplasmic reticulum membrane |
Accession | Q9NR96 |
Clone Number | S-3019 |
Antibody Type | Rat mAb |
Isotype | IgG2a,k |
Application | FCM |
Reactivity | Hu |
Positive Sample | Human PBMC |
Purification | Protein G |
Concentration | 0.2 mg/ml |
Conjugation | Alexa Fluor® 488 |
Physical Appearance | Liquid |
Storage Buffer | PBS, 1% BSA, 0.3% Proclin 300 |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
application | dilution | species |
FCM | 1.25μl per million cells in 100μl volume | Hu |
Background
CD289, also known as Toll-like receptor 9 (TLR9), is a ~115-120 kDa intracellular pattern-recognition receptor of the Toll-like receptor family that is preferentially expressed in immune-cell-rich tissues such as spleen, lymph node, bone marrow, and peripheral blood leukocytes; it senses unmethylated CpG dinucleotides in bacterial DNA and, upon activation via the adaptor protein MyD88, triggers NF-κB signaling and subsequent production of inflammatory cytokines, thereby orchestrating a T-helper-1-like innate immune response, as evidenced by impaired splenocyte proliferation, macrophage cytokine release, and dendritic-cell maturation in TLR9-deficient mice.
Picture
Picture
FC
